Merck Insomnia Drug Safe Only in Low Doses

REPLAY VIDEO
Your next video will start in
Pause
  • Info

  • Comments

May 23 (Bloomberg) -- Merck & Co.’s experimental insomnia drug, meant to be a less disruptive alternative to Sanofi’s Ambien sleeping pill, is safe only at lower doses, U.S. regulatory advisers said. Olivia Sterns reports on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change